This market research report gives an insight into Metabolomics Technologies - Combined/Integrated Systems, Hardware Systems for metabolic analytics and Software Systems. Estimates and projections for the total global Metabolomics Technologies' market are given by geographic regions encompassing United States, Canada, Europe, Asia-Pacific, and Japan. Business profiles of 26 major companies are discussed in the research report. The research report covers 229 companies that are engaged in Metabolomics research and supply of products and/or services. Major Contract Research Organizations and Universities serving Metabolomics market are also covered in the Corporate Directory section of this research report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. A total of 91 exhibits complements the market research report.

Free Sample Research Report

Download Table of contents

Though metabolomics is still in evolution stage, biotechnology and/or pharmaceutical industries are expected to apply this technology more intensely in the near future. The advantage of metabolomics is expected to provide effective results throughput the drug discovery and development process – the discovery, pre-clinical development, clinical trials and post market drug monitoring stages.

Research in the industry is also on an upswing owing to the enthusiasm of pharmaceutical and biotechnology companies. They are mainly concentrating on the application of metabolite profiles as potential tools for drug discovery. Traditionally, mass spectrometry and nuclear magnetic resonance are the two major platforms used for the study of metabolomics.

Already research in genomics and proteomics has enabled pharmaceutical companies to develop a vast database of potential drug targets by comparing metabolic profiles of diseased and normal samples for validating and prioritizing potential targets. The study of specific metabolites — substrates/products of a particular gene or protein — helps scientists to understand the full extent of a reaction.

One major area in metabolomics where the pharma industry stands to benefit is toxicology studies. The metabolic profiling of samples treated with investigational drugs can be compared to untreated samples, and variations in the two metabolic profiles can provide tremendous insight.

Global metabolomics market is estimated at US$689.25 million in 2007. Combined systems technology is poised to register the highest growth rate and is expected to emerge as the largest technology for metabolomics study during the period 2005-2012. The United States is the leading market (expected to account for 41% of global market share in 2009) for metabolomics, though its market share may drop by the year 2012. Asia-Pacific and European regions are strong markets to contend with in the near future.

Acadia Pharmaceuticals, Inc. (USA)
Accelrys, Inc. (USA)
Agilent Technologies, Inc. (USA)
Amphora Discovery Corporation (USA)
Applied Biosystems Group (USA)
Avogadro (France)
BG Medicine, Inc. (USA)
Biocrates Life Sciences GmbH (Austria)
Bio-Rad Laboratories, Inc. (USA)
Bruker Biosciences Corporation (USA)
Bruker Daltonics, Inc. (USA)
Caliper Life Sciences, Inc. (USA)
Chenomx, Inc. (Canada)
Cogenics (USA)
Genedata AG (Switzerland)
Genego, Inc. (USA)
Human Metabolome Technologies, Inc. (Japan)
Infometrix, Inc. (USA)
MDS Sciex (Canada)
Metabolon, Inc. (USA)
Metabometrix Ltd. (UK)
Metanomics GmbH (Germany)
Pharmaceutical Product Development, Inc. (Canada)
Phenomenome Discoveries, Inc. (Canada)
Shimadzu Corporation (Japan)
SiDMAP (USA)
Thermo Fisher Scientific, Inc. (USA)
Waters Corporation (USA)

For those who are intrested to buy the report by chapter:

CHAPTER	TITLE	SHORT DESCRIPTION	PRICE (US$)
I	Scope and Methodology	Provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used. * Will be delivered free with purchase of any of the other chapters mentioned below.	FREE*
II	Report Synopsis	Synopsis of the report summarizes the Metabolomics Technologies market by - Combined Systems, Hardware Systems and Software Systems. It provides the market values in US$ for each segment in several geographic regions such as the US, Canada, Europe, Asia-Pacific, and Japan. It also includes list of major companies in different regions that are engaged in the field of Metabolomics.	$1000
III	Product / Technology Research	This chapter gives an insight into Metabolomics market including definitions, segmentation and applications. The process and the procedure for metabolomic profiling are also discussed. The chapter provides market values in US$ (for the period 2005 through 2012) for Metabolomics Technologies. The chapter also includes product trends and potential opportunities.	$875
IV	Market Dynamics	Market Dynamics chapter provides information on global markets for Metabolomics. The chapter includes global market analysis (in US$) by geographic region; analysis of each region by technologies; a brief business profile of major global companies; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches etc. The section also includes market overview and an industry outlook.	$1200
V	Corporate Directory	This chapter provides the region-wise list of 229 companies, CROs and academic institutions that are engaged in Metabolomics research, products and/or services.	$300